Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2918)
All Articles published online
|
Apr 14, 2005 (publication date) through May 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang WS, Lin JK, Lin TC, Chiou TJ, Liu JH, Yen CC, Chen PM. Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma. World J Gastroenterol 2005; 11(14): 2166-2170 [PMID: 15810086 DOI: 10.3748/wjg.v11.i14.2166] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i14/2166.htm |
| Number | Citing Articles |
| 1 |
J Liu, N-L Sun, J Yang, J-H Huang. Effects of Losartan on Fibrinolytic Parameters and von Willebrand Factor in Chinese Subjects with Hypertension: A Comparative Study versus Atenolol. Journal of International Medical Research 2009; 37(3): 595 doi: 10.1177/147323000903700301
|
| 2 |
Samuel Wan Ki Wong, Sze Keong Tey, Xiaowen Mao, Hiu Ling Fung, Zhi‐Jie Xiao, Danny Ka Ho Wong, Lung‐Yi Mak, Man‐Fung Yuen, Irene Oi‐Lin Ng, Jing Ping Yun, Yi Gao, Judy Wai Ping Yam. Small Extracellular Vesicle‐Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma. Advanced Science 2023; 10(26) doi: 10.1002/advs.202302677
|
| 3 |
Christoph Schwarz, Fabian Fitschek, Martina Mittlböck, Veronika Saukel, Simona Bota, Monika Ferlitsch, Arnulf Ferlitsch, Martin Bodingbauer, Klaus Kaczirek. von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma. Gut and Liver 2020; 14(2): 218 doi: 10.5009/gnl17115
|
| 4 |
D. R. Weiss, C. Eiche, C. Hupke, V. S. Schellerer, A. K. Keller, E. F. Strasser, J. Ringwald, R. Zimmermann, R. Eckstein. The structure of the von Willebrand factor is not altered in patients with colorectal carcinoma. Colorectal Disease 2012; 14(12): 1500 doi: 10.1111/j.1463-1318.2012.03049.x
|
| 5 |
Anne Polk, Kirsten Vistisen, Merete Vaage-Nilsen, Dorte L Nielsen. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity. BMC Pharmacology and Toxicology 2014; 15(1) doi: 10.1186/2050-6511-15-47
|
| 6 |
Renyong Guo, Jiezuan Yang, Xia Liu, Jianping Wu, Yu Chen. Increased von Willebrand factor over decreased ADAMTS‐13 activity is associated with poor prognosis in patients with advanced non‐small‐cell lung cancer. Journal of Clinical Laboratory Analysis 2018; 32(1) doi: 10.1002/jcla.22219
|
| 7 |
M. Pépin, A. Kleinjan, D. Hajage, H.R. Büller, M. Di Nisio, P.W. Kamphuisen, L. Salomon, A. Veyradier, A. Stepanian, I. Mahé. ADAMTS‐13 and von Willebrand factor predict venous thromboembolism in patients with cancer. Journal of Thrombosis and Haemostasis 2016; 14(2): 306 doi: 10.1111/jth.13205
|
| 8 |
Hanna L. Obermeier, Julia Riedl, Cihan Ay, Silvia Koder, Peter Quehenberger, Rupert Bartsch, Alexandra Kaider, Christoph C. Zielinski, Ingrid Pabinger. The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study. Research and Practice in Thrombosis and Haemostasis 2019; 3(3): 503 doi: 10.1002/rth2.12197
|
| 9 |
K. N. Grigoreva, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, D. A. Ponomarev, K. Yu. Tsvetnova, D. A. Doronicheva, A. R. Mamaeva, K. V. Mekhedova, G. Rizzo, J.-C. Gris, I. Elalamy, A. D. Makatsariya. Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice. Obstetrics, Gynecology and Reproduction 2021; 15(1): 93 doi: 10.17749/2313-7347/ob.gyn.rep.2021.203
|
| 10 |
Virginie Terraube, Isabelle Marx, Cécile V. Denis. Role of von Willebrand factor in tumor metastasis. Thrombosis Research 2007; 120: S64 doi: 10.1016/S0049-3848(07)70132-9
|
| 11 |
Yi Liu, Xiwei Wang, Sanglin Li, Huaidong Hu, Dazhi Zhang, Peng Hu, Yixuan Yang, Hong Ren. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: A quantitative proteomic based study. Journal of Proteomics 2014; 106: 99 doi: 10.1016/j.jprot.2014.04.021
|
| 12 |
Anahita Mojiri, Konstantin Stoletov, Maria Areli Lorenzana Carrillo, Lian Willetts, Saket Jain, Roseline Godbout, Paul Jurasz, Consolato M. Sergi, David D. Eisenstat, John D. Lewis, Nadia Jahroudi. Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin. Oncotarget 2017; 8(8): 13015 doi: 10.18632/oncotarget.14273
|
| 13 |
Alok A. Khorana, Nigel Mackman, Anna Falanga, Ingrid Pabinger, Simon Noble, Walter Ageno, Florian Moik, Agnes Y. Y. Lee. Cancer-associated venous thromboembolism. Nature Reviews Disease Primers 2022; 8(1) doi: 10.1038/s41572-022-00336-y
|
| 14 |
I. Gil-Bazo, J. A Díaz González, J. Rodríguez, J. Cortés, E. Calvo, J. A. Páramo, J. García-Foncillas. Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: Do we have enough evidence?. World Journal of Gastroenterology 2005; 11(38): 6072-6073 doi: 10.3748/wjg.v11.i38.6072
|
| 15 |
Abigail C. Hielscher, Connie Qiu, Sharon Gerecht. Breast cancer cell-derived matrix supports vascular morphogenesis. American Journal of Physiology-Cell Physiology 2012; 302(8): C1243 doi: 10.1152/ajpcell.00011.2012
|
| 16 |
Chia Yin Goh, Sean Patmore, Albert Smolenski, Jane Howard, Shane Evans, Jamie O'Sullivan, Amanda McCann. The role of von Willebrand factor in breast cancer metastasis. Translational Oncology 2021; 14(4): 101033 doi: 10.1016/j.tranon.2021.101033
|
| 17 |
Sean Patmore, Sukhraj Pal S. Dhami, Jamie M. O'Sullivan. Von Willebrand factor and cancer; metastasis and coagulopathies. Journal of Thrombosis and Haemostasis 2020; 18(10): 2444 doi: 10.1111/jth.14976
|
| 18 |
Nikhil Gadewal, Abhiram Natu, Siddhartha Sen, Sukanya Rauniyar, Virupaksha Bastikar, Sanjay Gupta. Integrative epigenome-transcriptome analysis unravels cancer-specific over-expressed genes potentially regulating immune microenvironment in clear cell renal cell carcinoma. Biochimica et Biophysica Acta (BBA) - General Subjects 2024; 1868(5): 130596 doi: 10.1016/j.bbagen.2024.130596
|
| 19 |
Victor L. Serebruany. von Willebrand Factor for Predicting Bleeding and Mortality. Journal of the American College of Cardiology 2011; 57(25): 2505 doi: 10.1016/j.jacc.2011.02.025
|
| 20 |
Benjamín Rubio-Jurado, Luz-Ma-Adriana Balderas-Peña, Eduardo E. García-Luna, María G. Zavala-Cerna, Carlos Riebeling-Navarro, Pedro A. Reyes, Arnulfo H. Nava-Zavala. . Advances in Clinical Chemistry 2018; 85: 71 doi: 10.1016/bs.acc.2018.02.006
|
| 21 |
Wei Cai, Min Wang, Chen-yu Wang, Chan-yuan Zhao, Xiao-yu Zhang, Quan Zhou, Wen-jie Zhao, Feng Yang, Chen-li Zhang, Ai-jun Yang, Jing-fei Dong, Min Li. Extracellular vesicles, hyperadhesive von willebrand factor, and outcomes of gastric cancer: a clinical observational study. Medical Oncology 2023; 40(5) doi: 10.1007/s12032-023-01950-w
|
| 22 |
Suguru Hayase, Yoshihito Sasaki, Tsutomu Matsubara, Daekwan Seo, Masaaki Miyakoshi, Tsubasa Murata, Takashi Ozaki, Kennichi Kakudo, Kensuke Kumamoto, Kris Ylaya, Sheue-yann Cheng, Snorri S. Thorgeirsson, Stephen M. Hewitt, Jerrold M. Ward, Shioko Kimura. Expression of Stanniocalcin 1 in Thyroid Side Population Cells and Thyroid Cancer Cells. Thyroid 2015; 25(4): 425 doi: 10.1089/thy.2014.0464
|
| 23 |
Ruth Anne Laura Willems, Charlotte Biesmans, Elena Campello, Paolo Simioni, Bas de Laat, Judith de Vos-Geelen, Mark Roest, Hugo ten Cate. Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer. Seminars in Thrombosis and Hemostasis 2024; 50(03): 429 doi: 10.1055/s-0043-1777304
|
| 24 |
Massimo Franchini, Francesco Frattini, Silvia Crestani, Carlo Bonfanti, Giuseppe Lippi. von Willebrand factor and cancer: A renewed interest. Thrombosis Research 2013; 131(4): 290 doi: 10.1016/j.thromres.2013.01.015
|
| 25 |
Francesca Elice, Jack Jacoub, Frederick R. Rickles, Anna Falanga, Francesco Rodeghiero. Hemostatic complications of angiogenesis inhibitors in cancer patients. American Journal of Hematology 2008; 83(11): 862 doi: 10.1002/ajh.21277
|
| 26 |
Søren Astrup Jensen, Jens Benn Sørensen. 5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity. Cancer Chemotherapy and Pharmacology 2012; 69(1): 57 doi: 10.1007/s00280-011-1669-x
|
| 27 |
Lukas Goertz, Stefan Werner Schneider, Anna Desch, Frank Thomas Mayer, Julian Koett, Kai Nowak, Ioannis Karampinis, Michael K. Bohlmann, Viktor Umansky, Alexander Thomas Bauer. Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis. Oncotarget 2016; 7(42): 68527 doi: 10.18632/oncotarget.11832
|
| 28 |
Hiroaki Takaya, Hideto Kawaratani, Yuki Tsuji, Keisuke Nakanishi, Soichiro Saikawa, Shinya Sato, Yasuhiko Sawada, Kosuke Kaji, Yasushi Okura, Naotaka Shimozato, Mitsuteru Kitade, Takemi Akahane, Kei Moriya, Tadashi Namisaki, Akira Mitoro, Masanori Matsumoto, Hiroshi Fukui, Hitoshi Yoshiji. von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C. United European Gastroenterology Journal 2018; 6(9): 1401 doi: 10.1177/2050640618779660
|
| 29 |
Wiktoria Strasenburg, Jakub Jóźwicki, Justyna Durślewicz, Błażej Kuffel, Martyna Parol Kulczyk, Adam Kowalewski, Dariusz Grzanka, Tomasz Drewa, Jan Adamowicz. Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.909767
|
| 30 |
Rany Vorn, Sara Mithani, Christina Devoto, Timothy B. Meier, Chen Lai, Sijung Yun, Steven P. Broglio, Thomas W. McAllister, Christopher C. Giza, Hyung-Suk Kim, Daniel Huber, Jaroslaw Harezlak, Kenneth L. Cameron, Gerald McGinty, Jonathan Jackson, Kevin M. Guskiewicz, Jason P. Mihalik, Alison Brooks, Stefan Duma, Steven Rowson, Lindsay D. Nelson, Paul Pasquina, Michael A. McCrea, Jessica M. Gill. Proteomic Profiling of Plasma Biomarkers Associated With Return to Sport Following Concussion: Findings From the NCAA and Department of Defense CARE Consortium. Frontiers in Neurology 2022; 13 doi: 10.3389/fneur.2022.901238
|
| 31 |
Anahita Mojiri, Parnian Alavi, Nadia Jahroudi. Von Willebrand factor contribution to pathophysiology outside of von Willebrand disease. Microcirculation 2019; 26(4) doi: 10.1111/micc.12510
|
| 32 |
Kazushige Kawai, Toshiaki Watanabe. Colorectal cancer and hypercoagulability. Surgery Today 2014; 44(5): 797 doi: 10.1007/s00595-013-0606-5
|
| 33 |
Mika Enomoto, Hisashi Adachi, Ako Fukami, Ayako Yoshimura, Aya Obuchi, Sachiko Nakamura, Yume Nohara, Erika Nakao, Yoko Umeki, Kensuke Hori, Yoshihiro Fukumoto. Circulating Inflammatory and Hemostatic Biomarkers are Associated with All-Cause Death and Cancer Death in a Population of Community-Dwelling Japanese: The Tanushimaru Study. Clinical Medicine Insights: Cardiology 2014; : CMC.S17065 doi: 10.4137/CMC.S17065
|
| 34 |
Xin Zhang, Wandong Wang, Yun Wang, Guan Jiang. Identification of genes and pathways leading to metastasis and poor prognosis in melanoma. Aging 2021; 13(18): 22474 doi: 10.18632/aging.203554
|
| 35 |
Han-Seok Jeong, Da-Hye Lee, Seung-Hoon Kim, Chang-Han Lee, Hyun Mu Shin, Hang-Rae Kim, Chung-Hyun Cho. Hyperglycemia-induced oxidative stress promotes tumor metastasis by upregulating vWF expression in endothelial cells through the transcription factor GATA1. Oncogene 2022; 41(11): 1634 doi: 10.1038/s41388-022-02207-y
|
| 36 |
J.A. SHAVIT, D.G. MOTTO. Coagulation and metastasis – an unexpected role for von Willebrand factor. Journal of Thrombosis and Haemostasis 2006; 4(3): 517 doi: 10.1111/j.1538-7836.2006.01805.x
|
| 37 |
J.-B. Delhorme, L. Sattler, F. Severac, E. Triki, I. Gross, B. Romain, S. Rohr, L. Grunebaum, C. Brigand. Prognostic factors of hemorrhagic complications after oxaliplatin-based hyperthermic intraperitoneal chemotherapy: Toward routine preoperative dosage of Von Willebrand factor?. European Journal of Surgical Oncology (EJSO) 2017; 43(6): 1095 doi: 10.1016/j.ejso.2017.01.015
|
| 38 |
Ai-jun Yang, Min Wang, Yan Wang, Wei Cai, Qiang Li, Ting-ting Zhao, Li-han Zhang, Katie Houck, Xu Chen, Yan-ling Jin, Ji-ying Mu, Jing-fei Dong, Min Li. Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma. Oncogenesis 2018; 7(1) doi: 10.1038/s41389-017-0023-5
|
| 39 |
Marie-Alice Meuwis, E. Louis, Marie-Paule Merville. Contribution de la protéomique au diagnostic des cancers colorectaux. Acta Endoscopica 2007; 37(3): 295 doi: 10.1007/BF02961919
|
| 40 |
David Zaragoza-Huesca, Andrés Nieto-Olivares, Francisco García-Molina, Guillermo Ricote, Sofía Montenegro, Manuel Sánchez-Cánovas, Pedro Garrido-Rodríguez, Julia Peñas-Martínez, Vicente Vicente, Francisco Martínez, María Luisa Lozano, Alberto Carmona-Bayonas, Irene Martínez-Martínez. Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients. Cancers 2022; 14(13): 3106 doi: 10.3390/cancers14133106
|
| 41 |
Claire Comerford, Siobhan Glavey, John Quinn, Jamie M. O’Sullivan. The role of VWF/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies. Journal of Thrombosis and Haemostasis 2022; 20(8): 1766 doi: 10.1111/jth.15773
|
| 42 |
Kohei Tatsumi. The pathogenesis of cancer-associated thrombosis. International Journal of Hematology 2024; 119(5): 495 doi: 10.1007/s12185-024-03735-x
|
| 43 |
Yuanyuan Wang, Xiaobo Liu, Tobias Obser, Alexander T. Bauer, Martin Heyes, Sarah Starzonek, Mina Zulal, Karena Opitz, Leonie Ott, Sabine Riethdorf, Tobias Lange, Klaus Pantel, Gerd Bendas, Stefan W. Schneider, Marion Kusche-Gullberg, Christian Gorzelanny. Heparan sulfate dependent binding of plasmatic von Willebrand factor to blood circulating melanoma cells attenuates metastasis. Matrix Biology 2022; 111: 76 doi: 10.1016/j.matbio.2022.06.002
|
| 44 |
Bushra Fiza, Maheep Sinha, Anjana Sharma, Shehreen Akhtar. Study of Lipid Profile and Carcinoembryonic Antigen in Breast Cancer Patients
. Journal of Mahatma Gandhi University of Medical Sciences and Technology 2021; 5(1): 1 doi: 10.5005/jp-journals-10057-0114
|
| 45 |
Chanukya K. Colonne, Emmanuel J. Favaloro, Leonardo Pasalic. The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer. Healthcare 2022; 10(3): 557 doi: 10.3390/healthcare10030557
|
| 46 |
Bibek Aryal, Munekazu Yamakuchi, Toshiaki Shimizu, Jun Kadono, Akira Furoi, Kentaro Gejima, Kazunori Takenouchi, Teruo Komokata, Teruto Hashiguchi, Yutaka Imoto. Bivalent property of intra-platelet VWF in liver regeneration and HCC recurrence: A prospective multicenter study. Cancer Biomarkers 2019; 26(1): 51 doi: 10.3233/CBM-190168
|
| 47 |
Nadine Martins Castanheira, Anna K. Spanhofer, Sebastian Wiener, Stefanie Bobe, Hermann Schillers. Uptake of platelets by cancer cells and recycling of the platelet protein CD42a. Journal of Thrombosis and Haemostasis 2022; 20(1): 170 doi: 10.1111/jth.15543
|
| 48 |
Xia Yang, Hai-jian Sun, Zhi-rong Li, Hao Zhang, Wei-jun Yang, Bing Ni, Yu-zhang Wu. Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1083-6
|
| 49 |
Linhui Wang, Yutao Wang, Jianbin Bi. In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer. Functional & Integrative Genomics 2022; 22(5): 797 doi: 10.1007/s10142-022-00884-2
|
| 50 |
Ignacio Gil-Bazo, José Antonio Páramo, Jesús García-Foncillas. Nuevos factores pronósticos y predictivos en el cáncer colorrectal avanzado. Medicina Clínica 2006; 126(14): 541 doi: 10.1157/13087141
|
| 51 |
Shereef Elmoamly, Alaa Afif. Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?. Hematology 2018; 23(2): 89 doi: 10.1080/10245332.2017.1365458
|
| 52 |
Giovanni Marfia, Stefania Elena Navone, Claudia Fanizzi, Silvia Tabano, Chiara Pesenti, Loubna Abdel Hadi, Andrea Franzini, Manuela Caroli, Monica Miozzo, Laura Riboni, Paolo Rampini, Rolando Campanella. Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma. Cancer Medicine 2016; 5(8): 1783 doi: 10.1002/cam4.747
|
| 53 |
Changxia Shao, Songming Chen, Lixia Chen, Everardo Cobos, Jia‐Sheng Wang, Brian B. Haab, Weimin Gao. Antibody microarray analysis of serum glycans in esophageal squamous cell carcinoma cases and controls. PROTEOMICS – Clinical Applications 2009; 3(8): 923 doi: 10.1002/prca.200800245
|